Immunotherapy

A recent study showed that vitamin D supplementation during pregnancy has a protective effect on the respiratory health of children — specifically, it reduced wheezing.

Stereotactic ablative radiotherapy with immunotherapy significantly improvement EFS among patients with early-stage, treatment-naive or lung parenchymal recurrent node-negative non-small cell lung cancer, according to study results.

The obstacles that a boy with a fire ant allergy faced in accessing immunotherapy exemplify barriers to care in underserved populations, according to a case study published in The Journal of Allergy and Clinical Immunology: In Practice.

The FDA granted accelerated approval to elranatamab-bcmm for treatment of certain patients with multiple myeloma.

Verrica Pharmaceuticals Inc. has reported lesion clearance data from part one of an ongoing phase 2 study of VP-315 for the treatment of basal cell carcinoma, according to a press release from Verrica’s licensing partner, Lytix Biopharma.

Neoadjuvant talimogene laherparepvec conferred durable benefits for patients with advanced resectable melanoma, according to study results published in JAMA Oncology.

In this video interview, Ajay K. Nooka, MD, MPH, FACP,  associate professor of hematology and medical oncology at Emory School of Medicine, discusses BCMA-targeted immunotherapy for multiple myeloma.

Healio spoke with Charu Aggarwal, MD, MPH, about findings from her poster presentation on the impact on duration of immunotherapy on OS in metastatic non-small cell lung cancer presented at this year’s ASCO Annual Meeting.

A phase 3 trial of magrolimab plus azacitidine for higher-risk myelodysplastic syndrome has been terminated because of futility, according to a press release.

Healio spoke with Charu Aggarwal, MD, MPH, about data from the Keynote-789 trial presented at this year’s ASCO Annual Meeting.